Cathy R Zhang1, Lisa Cloonan1, Kaitlin M Fitzpatrick1, Allison S Kanakis1, Alison M Ayres1, Karen L Furie2, Jonathan Rosand3, Natalia S Rost4. 1. Stroke Service, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts. 2. Rhode Island Hospital, Providence, Rhode Island. 3. Stroke Service, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts; Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts. 4. Stroke Service, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts; Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: nrost@partners.org.
Abstract
BACKGROUND: Age is a well-known risk factor for both stroke and increased burden of white matter hyperintensity (WMH), as detected on magnetic resonance imaging (MRI) scans. However, in patients diagnosed with ischemic stroke (IS), WMH volume (WMHv) varies significantly across age groups. We sought to examine the determinants of WMH burden across the ages of stroke onset with the goal to uncover potential age-specific stroke prevention targets. METHODS: Adult subjects from an ongoing hospital-based cohort study of IS patients with admission brain MRI were categorized as having early (<55 years), late (>75 years), or average (55-75 years) age of stroke onset. WMHv was measured using a previously validated, MRI-based semi-automated method and normalized for linear regression analyses. RESULTS: Of 1008 IS subjects, 249 had early-onset stroke (24.7%), and 311 had late-onset stroke (30.9%). In multivariable analysis of WMHv using backward stepwise selection, only age (β = .02, P = .018), hypertension (β = .24, P = .049), and history of tobacco use (β = .38, P = .001) were independently associated with WMHv in patients with early-onset stroke, whereas male sex (β = -.30, P = .007), hyperlipidemia (β = -.27, P = .015), and current alcohol use (β = .23, P = .034) were independently associated with WMHv in patients with late-onset stroke. CONCLUSIONS: History of tobacco use is a strong independent predictor of WMH burden in patients with early-onset stroke, whereas age is no longer associated with WMHv in IS patients older than 75 years of age. These findings suggest that the major risk factors to target for stroke prevention differ across age groups and may be modifiable.
BACKGROUND: Age is a well-known risk factor for both stroke and increased burden of white matter hyperintensity (WMH), as detected on magnetic resonance imaging (MRI) scans. However, in patients diagnosed with ischemic stroke (IS), WMH volume (WMHv) varies significantly across age groups. We sought to examine the determinants of WMH burden across the ages of stroke onset with the goal to uncover potential age-specific stroke prevention targets. METHODS: Adult subjects from an ongoing hospital-based cohort study of IS patients with admission brain MRI were categorized as having early (<55 years), late (>75 years), or average (55-75 years) age of stroke onset. WMHv was measured using a previously validated, MRI-based semi-automated method and normalized for linear regression analyses. RESULTS: Of 1008 IS subjects, 249 had early-onset stroke (24.7%), and 311 had late-onset stroke (30.9%). In multivariable analysis of WMHv using backward stepwise selection, only age (β = .02, P = .018), hypertension (β = .24, P = .049), and history of tobacco use (β = .38, P = .001) were independently associated with WMHv in patients with early-onset stroke, whereas male sex (β = -.30, P = .007), hyperlipidemia (β = -.27, P = .015), and current alcohol use (β = .23, P = .034) were independently associated with WMHv in patients with late-onset stroke. CONCLUSIONS: History of tobacco use is a strong independent predictor of WMH burden in patients with early-onset stroke, whereas age is no longer associated with WMHv in IS patients older than 75 years of age. These findings suggest that the major risk factors to target for stroke prevention differ across age groups and may be modifiable.
Authors: Brett M Kissela; Jane C Khoury; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Opeolu Adeoye; Matthew L Flaherty; Pooja Khatri; Simona Ferioli; Felipe De Los Rios La Rosa; Joseph P Broderick; Dawn O Kleindorfer Journal: Neurology Date: 2012-10-10 Impact factor: 9.910
Authors: Irmhild Altmann-Schneider; Jeroen van der Grond; P Eline Slagboom; Rudi G J Westendorp; Andrea B Maier; Mark A van Buchem; Anton J M de Craen Journal: Stroke Date: 2012-11-15 Impact factor: 7.914
Authors: Fan Z Caprio; Matthew B Maas; Neil F Rosenberg; Adam R Kosteva; Richard A Bernstein; Mark J Alberts; Shyam Prabhakaran; Andrew M Naidech Journal: Stroke Date: 2013-02-07 Impact factor: 7.914
Authors: Bettina von Sarnowski; Ulf Schminke; Turgut Tatlisumak; Jukka Putaala; Ulrike Grittner; Manfred Kaps; William O Tobin; Justin A Kinsella; Dominick J H McCabe; Michael G Hennerici; Franz Fazekas; Bo Norrving; Christof Kessler; Arndt Rolfs Journal: Neurology Date: 2013-03-06 Impact factor: 9.910
Authors: Natalia S Rost; Lisa Cloonan; Allison S Kanakis; Kaitlin M Fitzpatrick; Danielle R Azzariti; Virginia Clarke; Charles M Lourenco; Dominique P Germain; Juan M Politei; György A Homola; Claudia Sommer; Nurcan Üçeyler; Katherine B Sims Journal: Neurology Date: 2016-04-20 Impact factor: 9.910
Authors: Farzaneh A Sorond; Shawn Whitehead; Ken Arai; Douglas Arnold; S Thomas Carmichael; Charles De Carli; Marco Duering; Myriam Fornage; Rafael E Flores-Obando; Jonathan Graff-Radford; Edith Hamel; David C Hess; Massafumi Ihara; Majken K Jensen; Hugh S Markus; Axel Montagne; Gary Rosenberg; Andy Y Shih; Eric E Smith; Alex Thiel; Kai Hei Tse; Donna Wilcock; Frank Barone Journal: Geroscience Date: 2019-12-06 Impact factor: 7.713
Authors: Florian Dubost; Marleen de Bruijne; Marco Nardin; Adrian V Dalca; Kathleen L Donahue; Anne-Katrin Giese; Mark R Etherton; Ona Wu; Marius de Groot; Wiro Niessen; Meike Vernooij; Natalia S Rost; Markus D Schirmer Journal: Med Image Anal Date: 2020-04-18 Impact factor: 8.545
Authors: Simon R Cox; Stuart J Ritchie; David Alexander Dickie; Alison Pattie; Natalie A Royle; Janie Corley; Benjamin S Aribisala; Sarah E Harris; Maria Valdés Hernández; Alan J Gow; Susana Muñoz Maniega; John M Starr; Mark E Bastin; Joanna M Wardlaw; Ian J Deary Journal: Neurobiol Aging Date: 2017-02-27 Impact factor: 4.673
Authors: Markus D Schirmer; Adrian V Dalca; Ramesh Sridharan; Anne-Katrin Giese; Kathleen L Donahue; Marco J Nardin; Steven J T Mocking; Elissa C McIntosh; Petrea Frid; Johan Wasselius; John W Cole; Lukas Holmegaard; Christina Jern; Jordi Jimenez-Conde; Robin Lemmens; Arne G Lindgren; James F Meschia; Jaume Roquer; Tatjana Rundek; Ralph L Sacco; Reinhold Schmidt; Pankaj Sharma; Agnieszka Slowik; Vincent Thijs; Daniel Woo; Achala Vagal; Huichun Xu; Steven J Kittner; Patrick F McArdle; Braxton D Mitchell; Jonathan Rosand; Bradford B Worrall; Ona Wu; Polina Golland; Natalia S Rost Journal: Neuroimage Clin Date: 2019-05-29 Impact factor: 4.881